Stepwise Development of MAIT Cells in Mouse and Human

If a T cell is shaped by the thymus, it should bear the marks of that education: a memory phenotype, signs of prior activation, and evidence of having met its antigen. So here's the puzzle. Mucosal-associated invariant T cells, or MAIT cells, are among the most abundant T cells in the adult human body, making up one to four percent of all blood T cells. They look like memory cells. They respond to bacterial infection with the speed of innate immunity. And for years, no one could find them in the thymus at all. Every rule of T cell biology predicted they had to come from there, but the evidence said otherwise. Martin and colleagues set out to resolve that contradiction, and what they found reshaped how immunologists think about the boundary between innate and adaptive immunity. Start with what MAIT cells actually are. They carry an invariant T cell receptor alpha chain — in humans, always the same Valpha7.2 paired with Jalpha33 — and they're restricted by a molecule called MR1, which stands for MHC-related molecule 1. MR1 is nonpolymorphic, meaning it's essentially identical in every person, and instead of presenting peptides like conventional MHC molecules, it presents small metabolites derived from bacteria. This combination of a fixed receptor and a conserved presenting molecule means every human's MAIT cells are, in a sense, looking for the same thing. That evolutionary conservation across species suggested something important was going on. Yet how these cells developed, and why they looked like experienced memory cells even in young adults, was completely unresolved. MAIT cells were absent from mice raised without a microbiome, and their accumulation in the gut depended on commensal bacteria, adding another layer of confusion. Were they thymus-derived at all? If so, why couldn't anyone find them there in appreciable numbers? The team's first breakthrough was technical. They generated a monoclonal antibody called 3C10 that specifically recognizes the human Valpha7.2 segment. Combined with the marker CD161, this allowed them to identify MAIT cells directly in human tissue samples with a precision that hadn't been possible before. When they looked at human thymuses with this tool, they found MAIT cells — rare, but present. Crucially, the small population of 3C10-positive, CD161-high double-negative thymocytes used the Jalpha33 segment in fifty to one hundred percent of their sequences. Almost half of these thymic MAIT cells displayed a naïve phenotype: CD45RA positive, CD27 positive, and CD45RO low. These were freshly minted cells, not memory cells that had recirculated back into the thymus. That naïve phenotype was the first clean piece of evidence that the thymus was producing MAIT cells from scratch. To pin down whether thymic selection actually required MR1, the team turned to mouse models. They engineered mice carrying both the invariant mouse V alpha nineteen-J alpha thirty-three T cell receptor alpha chain and a MAIT-specific T cell receptor beta chain. They then used fetal thymic organ culture — growing embryonic thymic tissue outside the body under controlled conditions — to investigate what happens when MR1 is present versus absent. The answer was unambiguous. In the presence of MR1, mature thymocytes showed a strong bias toward the V beta six and V beta eight segments characteristic of MAIT cells. Remove MR1, and that bias collapsed — V beta six representation dropped significantly, and V beta eight fell with a p-value below 0.0001. In intact double-transgenic animals lacking MR1, the frequency and number of mature thymocytes fell by a factor of six to eight. MAIT cells need MR1 to be selected in the thymus, full stop. Then came the question of B cells. B cells were already known to be required for MAIT cell accumulation in the gut. But were they needed for the thymic selection step itself? To find out, the team generated double-transgenic mice on a RAG-deficient background — animals that have no B cells, no conventional T cells, and nothing but the engineered MAIT T cell receptor. In these mice, in the presence of MR1, mature double-negative and CD eight thymocytes still appeared. In the absence of MR1, no mature thymocytes formed at all. B cells are not needed for thymic selection. Martin and colleagues conclude that the selecting element is MR1 expressed on a hematopoietic cell that is neither a B cell nor a conventional T cell — not thymic epithelium, but something else in the thymic environment whose exact identity remains an open question. So the thymus selects MAIT cells and exports them as naïve cells. What happens next is where B cells and bacteria become essential. In the RAG-deficient double-transgenic mice, even when thymic selection has occurred, MAIT cells simply don't accumulate in the periphery. Mice lacking MR1 in this background had a peripheral T cell count of roughly fifteen hundred cells — essentially nothing. MR1-positive mice had modest numbers in the mesenteric lymph node, around one hundred and thirty thousand. Then the team did an add-back experiment. They transferred T cell-depleted splenocytes — essentially supplying B cells — into these RAG-deficient hosts and counted MAIT cells two weeks later. When MR1-positive B cells were transferred into MR1-positive hosts, peripheral MAIT cells expanded to around one million. The transfer of MR1-negative B cells into MR1-positive hosts still produced expansion but only to about three hundred and forty thousand — roughly a third as many. Transfers into MR1-negative hosts yielded only modest increases regardless of the B cells provided. The math is telling: MR1-positive B cells in an MR1-positive host produced roughly eight times the expansion seen with MR1-negative B cells, suggesting that direct, cognate MR1-dependent interactions between B cells and MAIT cells drive the bulk of peripheral accumulation. After B cell transfer, the expanded MAIT cells acquired a memory phenotype. B cells are not a bystander effect; they are the trigger for the post-thymic transition. The human data fit this sequence cleanly. Cord blood contains very few MAIT cells, and those present are naïve. After birth, exposure to the microbial world drives dramatic expansion. By adulthood, MAIT cells constitute one to four percent of blood T cells and display a uniform memory-effector phenotype, including expression of the transcription factor ZBTB16. The microbiome is the training ground that, together with B cells, converts thymic naïveté into an abundant, experienced peripheral compartment. Now consider how different this is from the closest comparison case: natural killer T cells. Natural killer T cells also use an invariant T cell receptor alpha chain and are restricted by a nonpolymorphic MHC molecule — CD1d rather than MR1. They also behave like innate lymphocytes, but the developmental logic is almost the mirror image of MAIT cells. NKT cells expand and acquire their memory-effector phenotype inside the thymus. MAIT cells do it outside. NKT cell development requires a signaling adaptor called SAP, encoded by the SH2D1A gene, whose loss causes X-linked lymphoproliferative disease and eliminates NKT cells. Martin and colleagues measured MAIT cells in five SAP-deficient patients and found them present in normal numbers — even though NKT cells were undetectable in those same patients. The SLAM-SAP-Fyn signaling pathway that NKT cells depend on is simply not involved in MAIT cell development. And ZBTB16, the transcription factor that programs NKT cells' innate-memory identity from the earliest stages of thymic differentiation, tells a similarly divergent story in MAIT cells. It's expressed by human peripheral MAIT cells after postnatal expansion, but not by thymic MAIT cells, and not by mouse MAIT cells at all, which remain naïve in the periphery and don't expand substantially. Three distinctions — SAP independence, delayed and species-specific ZBTB16 induction, and peripheral rather than intrathymic expansion — make MAIT cell ontogeny genuinely its own thing, not a variant of NKT biology. Put it all together, and the picture is a two-stage developmental program. Stage one: intra-thymic, MR1-dependent selection on an unidentified non-B, non-T hematopoietic cell. Stage two: peripheral expansion driven by B cells and commensal bacteria, producing the abundant memory-phenotype population seen in adult blood. What makes this model matter beyond immunology is what it says about why MAIT cell numbers vary so much between individuals. The peripheral stage is sensitive to microbial colonization and B cell availability, both of which differ enormously across people and environments. It also places MAIT cells squarely at the interface of innate and adaptive immunity: selected like adaptive T cells by a specific receptor-ligand interaction, and expanded and activated by cues that look more like innate immune priming. The line between those two systems keeps getting harder to draw. MAIT cells are one of the clearest examples of why. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.